CXCL12 and neurodegenerative disease: Several studies have demonstrated that there is a powerful correlation between the dysregulated CXCR4 and neurodegenerative diseases including AD, and the inhibition of CXCR4/CXCL12 signaling pathways is able to alleviate glutamate release mediated toxic cascade and neuronal apoptosis (60, 61).